Qvar is indicated in children aged 5 and over, adolescents and adults for the prophylactic management of mild, moderate or severe asthma.
Teva Pharmaceutical Industries Ltd. announced that the FDA has approved QVAR RediHaler (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler...
Prophylactic management of mild, moderate or severe asthma.